Cancer drug trial cut short after enrolling only 7 patients
NCT ID NCT04169074
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 35 times
Summary
This study tested whether the drug abemaciclib could shrink tumors in people with HPV-negative head and neck cancer before they had surgery. Only 7 patients took part, and the trial was stopped early. The goal was to see if the drug could help control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HNSCC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
George Washington Cancer Center
Washington D.C., District of Columbia, 20037, United States
-
University of Arizona
Tucson, Arizona, 85719, United States
Conditions
Explore the condition pages connected to this study.